Retour
41
Fourchette du Jour
517,63 €
536,02 €
Fourchette 52 Semaines
266,98 €
548,12 €
Volume
539 645
Moyenne 50J / 200J
491,10 €
/
415,89 €
Clôture Précédente
521,22 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 17,5 | 0,4 |
| P/B | 3,3 | 2,9 |
| ROE % | 19,7 | 3,9 |
| Net Margin % | 41,9 | 3,8 |
| Rev Growth 5Y % | 17,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
579,83 €
+9.0%
Low: 447,00 €
High: 645,00 €
P/E Prévisionnel
17,7
BPA Prévisionnel
29,41 €
Croissance BPA (est.)
+0,0%
CA Est.
3,3 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
53,13 €
46,51 € – 59,63 €
|
5,8 B | 4 |
| FY2029 |
46,47 €
40,68 € – 52,15 €
|
5,1 B | 4 |
| FY2028 |
38,67 €
27,43 € – 51,06 €
|
4,3 B | 10 |
Points Clés
Revenue grew 17,22% annually over 5 years — strong growth
ROE of 19,71% — decent returns on equity
Net margin of 41,94% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 1,04B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,61%
Croissance
Revenue Growth (5Y)
17,22%
Revenue (1Y)10,61%
Earnings (1Y)11,68%
FCF Growth (3Y)17,99%
Qualité
Return on Equity
19,71%
ROIC15,77%
Net Margin41,94%
Op. Margin46,89%
Sécurité
Debt / Equity
0,00
Current Ratio6,60
Interest Coverage76,54
Valorisation
P/E Ratio
17,46
P/B Ratio3,28
EV/EBITDA14,57
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,61% | Revenue Growth (3Y) | 16,94% |
| Earnings Growth (1Y) | 11,68% | Earnings Growth (3Y) | 16,42% |
| Revenue Growth (5Y) | 17,22% | Earnings Growth (5Y) | 29,42% |
| Profitability | |||
| Revenue (TTM) | 3,18B | Net Income (TTM) | 1,33B |
| ROE | 19,71% | ROA | 16,94% |
| Gross Margin | 87,92% | Operating Margin | 46,89% |
| Net Margin | 41,94% | Free Cash Flow (TTM) | 1,04B |
| ROIC | 15,77% | FCF Growth (3Y) | 17,99% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 6,60 |
| Interest Coverage | 76,54 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 17,46 | P/B Ratio | 3,28 |
| P/S Ratio | 7,32 | PEG Ratio | 1,16 |
| EV/EBITDA | 14,57 | Dividend Yield | 0,00% |
| Market Cap | 23,31B | Enterprise Value | 21,75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,18B | 2,88B | 2,33B | 1,94B | 1,69B |
| Net Income | 1,33B | 1,20B | 984,80M | 727,30M | 475,80M |
| EPS (Diluted) | 27,86 | 24,64 | 19,81 | 15,00 | 10,06 |
| Gross Profit | 2,80B | 2,57B | 2,07B | 1,79B | 1,56B |
| Operating Income | 1,49B | 1,38B | 1,18B | 979,70M | 555,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7,88B | 7,36B | 7,17B | 6,04B | 5,17B |
| Total Liabilities | 783,80M | 920,00M | 1,18B | 1,25B | 1,21B |
| Shareholders' Equity | 7,10B | 6,44B | 5,98B | 4,80B | 3,96B |
| Total Debt | 0,0 | 300,00M | 700,00M | 800,00M | 800,00M |
| Cash & Equivalents | 1,56B | 1,70B | 1,21B | 961,20M | 894,80M |
| Current Assets | 3,70B | 3,87B | 3,55B | 3,38B | 2,32B |
| Current Liabilities | 560,60M | 738,10M | 804,40M | 343,20M | 305,40M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Balanced Risk
#105 of 151
Activité Récente
Entré
Balanced Risk
Mar 24, 2026